NRIXNurix Therapeutics Inc
−1.6% today · +29.6% over a year
2/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 94% of the instruments we score
Quality: among the best of its peers; priced lower than most peers. No dividend.
Nurix Therapeutics Inc (NRIX) valuation against sector peers: P/E 5.9 (sector median 30.7), P/B 1.8, EV/EBIT 3.5, free-cash-flow yield 21.3%, P/S 2.5.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | NRIX | Sector median | vs median |
|---|---|---|---|
| P/E | 5.9 | 30.7 · n=158 | 81% below |
| P/B | 1.8 | 4.0 · n=307 | 55% below |
| P/S | 2.5 | 4.1 · n=302 | 39% below |
| EV/EBIT | 3.5 | 25.8 · n=146 | 86% below |
| Free-cash-flow yield | 21.3% | 1.4% · n=291 | 1,407% above |
| Dividend yield | 0.00% | 0.00% · n=362 | — |
| Return on equity | 44.0% | −2.4% · n=308 | — |
| Return on invested capital | 106.9% | 0.6% · n=282 | 16,485% above |
| Gross margin | — | 63.3% · n=205 | — |
| Net debt / EBITDA | −2.41 | 1.27 · n=151 | 291% below |
Value factor: 96 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 48.9 | 33.5 | — | 1.5% | 0.6% | 6/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 42.0 | 8.3 | — | 3.0% | 1.9% | 8/10 |
| ABBVAbbVie | 50.5 | — | 27.8 | 3.6% | 2.9% | 6/10 |
| MRKMerck | 148.8 | 8.1 | — | 4.0% | 2.3% | 8/10 |
| UNHUnitedHealth | 22.9 | 3.5 | 17.3 | 6.3% | 2.2% | 10/10 |
| TMOThermo Fisher Scientific | 37.6 | 4.9 | 35.6 | 2.9% | 0.3% | 9/10 |
| AMGNAmgen | 26.8 | 17.5 | 23.2 | 3.8% | 2.1% | 8/10 |
| GILDGilead Sciences | — | 16.3 | — | 6.5% | 1.9% | 5/10 |
| ABTAbbott | 40.7 | 3.7 | 32.9 | 3.5% | 2.8% | 6/10 |
| PFEPfizer | 41.5 | 1.9 | — | 7.0% | 7.3% | 1/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Aug 2026 · filed 13 Oct 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.